Vivoryon Therapeutics N.V.
VVY.ASDrugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
PQ912 | Phase 2 | Early Alzheimers Disease | - | - |
PQ912 oral | Phase 2 | Alzheimer's Disease | - | - |
Frequently asked questions
What is in Vivoryon Therapeutics N.V.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Vivoryon Therapeutics N.V.'s (VVY.AS) pipeline across Phase 2. Its lead program is PQ912 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Vivoryon Therapeutics N.V.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Vivoryon Therapeutics N.V. (VVY.AS) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track VVY.AS biotech catalysts?→
Add VVY.AS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Vivoryon Therapeutics N.V.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.